Dr. Kensei Tsuzaka, M.D., Ph.D., Appointed as Chief Advisor of Regenerative Medicine at Tokyo Relife Clinic
Tokyo Relife has appointed Dr. Kensei Tsuzaka as the Chief Advisor of Regenerative Medicine at Tokyo Relife Clinic, effective April 1, 2026. Dr. Tsuzaka brings extensive expertise in internal medicine and rheumatology to enhance the clinic's advanced regenerative medicine and longevity programs.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 20:00
- 🔍 Collected: April 1, 2026 at 16:47
- 🤖 AI Analyzed: April 17, 2026 at 10:11 (377h 23m after Collected)
Tokyo Relife (Location: Ginza, Chuo-ku, Tokyo; CEO: Yoshiaki Furuyama) is pleased to announce that Dr. Kensei Tsuzaka has been appointed as the Chief Advisor of Regenerative Medicine at Tokyo Relife Clinic, effective April 1, 2026, with the aim of advancing the field of regenerative medicine and further strengthening the clinic's medical framework.
1. Significance of the Appointment
After graduating from the Keio University School of Medicine, Dr. Tsuzaka earned his Ph.D. in medicine from the same university. He has international research experience, having engaged in basic medical research at the Oklahoma Medical Research Foundation in the United States. Since returning to Japan, he has held positions including Keio University Hospital staff, Lecturer at Saitama Medical University, and Associate Professor at Tokyo Dental College, accumulating extensive experience in clinical practice, research, and education within the fields of internal medicine and rheumatology.
His expertise in autoimmune diseases, inflammation control, and the integrated treatment of systemic diseases is a critical area for the clinical application of regenerative medicine. We have positioned his role as central to the practice of "Longevity Medicine," which our organization is currently promoting.
With this appointment, Tokyo Relife Clinic will advance the construction of a more sophisticated and comprehensive medical delivery system that fuses advanced regenerative medicine technologies—such as stem cell therapy, immune cell therapy, and exosome-related medicine—with internal medicine and immunological insights.
2. Profile
Chief Advisor of Regenerative Medicine, Tokyo Relife Clinic
Kensei Tsuzaka, M.D., Ph.D.
■ Career History
1988: Graduated from Keio University School of Medicine
1993: Researcher, Oklahoma Medical Research Foundation, USA
1996: Staff, Keio University Hospital
2000: Lecturer, Saitama Medical University
2009: Completed doctoral program at Keio University Graduate School; obtained Ph.D. in Medicine
2009: Associate Professor, Tokyo Dental College
2026: Chief Advisor of Regenerative Medicine, Tokyo Relife Clinic
■ Qualifications
Ph.D. in Medicine
Board Certified Physician, The Japanese Society of Internal Medicine
Board Certified Rheumatologist, Japan College of Rheumatology
■ Affiliated Societies
The Japanese Society of Internal Medicine
Japan College of Rheumatology
Member, American College of Rheumatology (ACR)
3. Comments from Chief Advisor Kensei Tsuzaka
I am deeply honored to join Tokyo Relife Clinic as the Chief Advisor of Regenerative Medicine.
To date, I have been involved in clinical practice, research, and education in the field of internal medicine, focusing primarily on autoimmune diseases and inflammation control. In recent years, the progress of regenerative medicine has opened new possibilities for diseases that were previously difficult to treat fundamentally.
Moving forward, I will leverage the immunological and internal medicine knowledge I have cultivated to realize comprehensive and personalized medical care through the fusion of these fields with regenerative medicine.
Furthermore, I am committed to prioritizing safety and efficacy based on scientific evidence, and I will strive to provide medical care that is truly valuable to our patients.
About Tokyo Relife
"Tokyo Relife Clinic," operated by Tokyo Relife, is a medical institution positioned as a core hub for implementing research results into clinical practice. The clinic is equipped with a Cell Processing Center (CPC) designed to high safety management standards, providing medical care that emphasizes quality, safety, and traceability in stem cell therapy, NK cell therapy, fibroblast therapy, and exosome-related medicine. Furthermore, through personalized treatment design and a highly private environment, we are realizing advanced longevity medicine that also considers the quality of the medical experience.
Tokyo Relife Clinic
TORAYA Ginza Building 6F-8F, 7-8-17 Ginza, Chuo-ku, Tokyo 104-0061
TEL: 0120-660-329 (Reception hours: 10:00–19:00)
Official Website: https://www.tokyo-relife.com
Inquiry Form: https://tokyo-relife.com/contact
*Please select "Other" in the form to make an inquiry.
1. Significance of the Appointment
After graduating from the Keio University School of Medicine, Dr. Tsuzaka earned his Ph.D. in medicine from the same university. He has international research experience, having engaged in basic medical research at the Oklahoma Medical Research Foundation in the United States. Since returning to Japan, he has held positions including Keio University Hospital staff, Lecturer at Saitama Medical University, and Associate Professor at Tokyo Dental College, accumulating extensive experience in clinical practice, research, and education within the fields of internal medicine and rheumatology.
His expertise in autoimmune diseases, inflammation control, and the integrated treatment of systemic diseases is a critical area for the clinical application of regenerative medicine. We have positioned his role as central to the practice of "Longevity Medicine," which our organization is currently promoting.
With this appointment, Tokyo Relife Clinic will advance the construction of a more sophisticated and comprehensive medical delivery system that fuses advanced regenerative medicine technologies—such as stem cell therapy, immune cell therapy, and exosome-related medicine—with internal medicine and immunological insights.
2. Profile
Chief Advisor of Regenerative Medicine, Tokyo Relife Clinic
Kensei Tsuzaka, M.D., Ph.D.
■ Career History
1988: Graduated from Keio University School of Medicine
1993: Researcher, Oklahoma Medical Research Foundation, USA
1996: Staff, Keio University Hospital
2000: Lecturer, Saitama Medical University
2009: Completed doctoral program at Keio University Graduate School; obtained Ph.D. in Medicine
2009: Associate Professor, Tokyo Dental College
2026: Chief Advisor of Regenerative Medicine, Tokyo Relife Clinic
■ Qualifications
Ph.D. in Medicine
Board Certified Physician, The Japanese Society of Internal Medicine
Board Certified Rheumatologist, Japan College of Rheumatology
■ Affiliated Societies
The Japanese Society of Internal Medicine
Japan College of Rheumatology
Member, American College of Rheumatology (ACR)
3. Comments from Chief Advisor Kensei Tsuzaka
I am deeply honored to join Tokyo Relife Clinic as the Chief Advisor of Regenerative Medicine.
To date, I have been involved in clinical practice, research, and education in the field of internal medicine, focusing primarily on autoimmune diseases and inflammation control. In recent years, the progress of regenerative medicine has opened new possibilities for diseases that were previously difficult to treat fundamentally.
Moving forward, I will leverage the immunological and internal medicine knowledge I have cultivated to realize comprehensive and personalized medical care through the fusion of these fields with regenerative medicine.
Furthermore, I am committed to prioritizing safety and efficacy based on scientific evidence, and I will strive to provide medical care that is truly valuable to our patients.
About Tokyo Relife
"Tokyo Relife Clinic," operated by Tokyo Relife, is a medical institution positioned as a core hub for implementing research results into clinical practice. The clinic is equipped with a Cell Processing Center (CPC) designed to high safety management standards, providing medical care that emphasizes quality, safety, and traceability in stem cell therapy, NK cell therapy, fibroblast therapy, and exosome-related medicine. Furthermore, through personalized treatment design and a highly private environment, we are realizing advanced longevity medicine that also considers the quality of the medical experience.
Tokyo Relife Clinic
TORAYA Ginza Building 6F-8F, 7-8-17 Ginza, Chuo-ku, Tokyo 104-0061
TEL: 0120-660-329 (Reception hours: 10:00–19:00)
Official Website: https://www.tokyo-relife.com
Inquiry Form: https://tokyo-relife.com/contact
*Please select "Other" in the form to make an inquiry.